title: Neuropathologies associated with dideoxycytosine: a preliminary assessment.
authors.affiliation: Food and Drug Administration, Rockville, Maryland 20857.
authors.forename: D E
authors.initials: DE
authors.lastname: Morse
authors.forename: G
authors.initials: G
authors.lastname: Evoniuk
authors.forename: P L
authors.initials: PL
authors.lastname: Black
authors.forename: M A
authors.initials: MA
authors.lastname: Ussery
mesh_terms: D000161:Acoustic Stimulation; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use / Q000633:toxicity*; D001835:Body Weight / Q000187:drug effects; D004285:Dogs; D004327:Drinking Behavior / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D000882:Haplorhini; D007942:Leukemia, Experimental / Q000188:drug therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009043:Motor Activity / Q000187:drug effects*; D009498:Neurotoxins / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D011925:Rauscher Virus; D013216:Reflex, Startle / Q000187:drug effects*; D016047:Zalcitabine / Q000633:toxicity*
chemical_list: D000998:Antiviral Agents; D009498:Neurotoxins; D016047:Zalcitabine